These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6831673)

  • 1. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL
    Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract]   [Full Text] [Related]  

  • 2. Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias. Clinical efficacy, safety, and side effects.
    Haggman DL; Maloney JD; Morant VA; Castle LW; King-Rankine M; Goormastic M
    Cleve Clin Q; 1986; 53(2):171-9. PubMed ID: 2874902
    [No Abstract]   [Full Text] [Related]  

  • 3. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmic action of intravenous mexiletine].
    Rizzo A; Fiorilli R; Sisto F; Lisanti P
    Cardiologia; 1984; 29(3-4):211-8. PubMed ID: 6541940
    [No Abstract]   [Full Text] [Related]  

  • 5. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
    Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine for ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1981 Apr; 47(4):895-902. PubMed ID: 6782850
    [No Abstract]   [Full Text] [Related]  

  • 7. Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine.
    Hoffmann A; Follath F; Burckhardt D
    Lancet; 1983 Mar; 1(8326 Pt 1):704-5. PubMed ID: 6132058
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
    Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
    Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
    Waspe LE; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
    Assey ME; Hudson WM; Hanger KH; Miller SC
    South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ventricular arrhythmias with mexiletine (Kö 1173).
    Talbot RG; Nimmo J; Julian DG; Clark RA; Neilson JM; Prescott LF
    Lancet; 1973 Aug; 2(7826):399-404. PubMed ID: 4124889
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiarrhythmic drug therapy for sporadic ventricular ectopic arrhythmias.
    Jelinek MV; Lohrbauer L; Lown B
    Circulation; 1974 Apr; 49(4):659-66. PubMed ID: 4817707
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.
    Campbell NP; Kelly JG; Shanks RG; Chaturvedi NC; Strong JE; Pantridge JF
    Lancet; 1973 Aug; 2(7826):404-7. PubMed ID: 4124890
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.
    Giardina EG; Wechsler ME
    J Am Coll Cardiol; 1990 Apr; 15(5):1138-45. PubMed ID: 2179362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Pantridge JF; Adgey AA
    Eur J Cardiol; 1977 Dec; 6(4):245-58. PubMed ID: 590296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.